Product: Zyprexa Intramuscular, Olanzapine for Injection, 10 MG per Single Use Vial, Rx only, Marketed by: Lilly USA, LLC, Indianapolis, IN 46285, NDC# 0002-7597-01
Reason for recall: cGMP deviations: Atypical appearance, decrease in size and change in color of the lyophilized cake of drug product.
Recall initiated: 20210629
Status: Terminated
Classification: Class II
Recall type: Voluntary: Firm initiated